AP2012006630A0 - Disubstituted tetrahydofuranyl compounds as antagonists of the bradykinin B1 receptor - Google Patents

Disubstituted tetrahydofuranyl compounds as antagonists of the bradykinin B1 receptor

Info

Publication number
AP2012006630A0
AP2012006630A0 AP2012006630A AP2012006630A AP2012006630A0 AP 2012006630 A0 AP2012006630 A0 AP 2012006630A0 AP 2012006630 A AP2012006630 A AP 2012006630A AP 2012006630 A AP2012006630 A AP 2012006630A AP 2012006630 A0 AP2012006630 A0 AP 2012006630A0
Authority
AP
ARIPO
Prior art keywords
tetrahydofuranyl
bradykinin
disubstituted
antagonists
receptor
Prior art date
Application number
AP2012006630A
Other languages
English (en)
Inventor
Henri Doods
Raimund Kuelzer
Nobert Hauel
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of AP2012006630A0 publication Critical patent/AP2012006630A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/443—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AP2012006630A 2010-08-20 2011-08-19 Disubstituted tetrahydofuranyl compounds as antagonists of the bradykinin B1 receptor AP2012006630A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10173489 2010-08-20
PCT/EP2011/064260 WO2012022795A1 (de) 2010-08-20 2011-08-19 Disubstituierte tetrahydofuranyl-verbindungen als antagonisten des bradykinin-b1-rezeptors

Publications (1)

Publication Number Publication Date
AP2012006630A0 true AP2012006630A0 (en) 2012-12-31

Family

ID=44510978

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2012006630A AP2012006630A0 (en) 2010-08-20 2011-08-19 Disubstituted tetrahydofuranyl compounds as antagonists of the bradykinin B1 receptor

Country Status (36)

Country Link
US (1) US8937073B2 (pl)
EP (1) EP2606042B1 (pl)
JP (1) JP5727011B2 (pl)
KR (1) KR101822371B1 (pl)
CN (1) CN103068817B (pl)
AP (1) AP2012006630A0 (pl)
AR (1) AR082507A1 (pl)
AU (1) AU2011290727B2 (pl)
BR (1) BR112013003752A2 (pl)
CA (1) CA2807086A1 (pl)
CL (1) CL2013000310A1 (pl)
CO (1) CO6680689A2 (pl)
CY (1) CY1115933T1 (pl)
DK (1) DK2606042T3 (pl)
EA (1) EA022787B1 (pl)
EC (1) ECSP13012495A (pl)
ES (1) ES2525296T3 (pl)
GE (1) GEP20146196B (pl)
HR (1) HRP20141172T1 (pl)
IL (1) IL224039A (pl)
MA (1) MA34578B1 (pl)
ME (1) ME01899B (pl)
MX (1) MX352548B (pl)
MY (1) MY156233A (pl)
NZ (1) NZ607435A (pl)
PE (1) PE20130810A1 (pl)
PH (1) PH12013500330A1 (pl)
PL (1) PL2606042T3 (pl)
PT (1) PT2606042E (pl)
RS (1) RS53622B1 (pl)
SG (1) SG187835A1 (pl)
SI (1) SI2606042T1 (pl)
TW (1) TWI548632B (pl)
UA (1) UA108765C2 (pl)
UY (1) UY33565A (pl)
WO (1) WO2012022795A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007034620A1 (de) * 2007-07-25 2009-01-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue B1-Antagonisten
ATE550321T1 (de) 2007-08-29 2012-04-15 Boehringer Ingelheim Int Neue bradykinin b1-antagonisten
US8937073B2 (en) 2010-08-20 2015-01-20 Boehringer Ingelheim International Gmbh Disubstituted tetrahydrofuranyl compounds and their use as B1-receptor antagonists
EP3200589B1 (en) 2014-09-10 2026-03-11 Temple University Of The Commonwealth System Of Higher Education Novel 5-hydroxytryptamine receptor 7 activity modulators and their method of use
US20180221365A1 (en) * 2015-05-12 2018-08-09 Temple University-Of The Commonwealth System Of Higher Education Novel sigma-2 receptor binders and their method of use
WO2021198534A1 (en) 2020-04-04 2021-10-07 Oxurion NV Plasma kallikrein inhibitors for use in the treatment of coronaviral disease
US11401303B2 (en) * 2020-06-15 2022-08-02 Taian City Qihang Biotechnology Co. Synthetic peptide BRAP and application in preparation of anti-inflammatory drug for COVID-19 thereof
WO2023148016A1 (en) 2022-02-04 2023-08-10 Oxurion NV Biomarker for plasma kallikrein inhibitor therapy response

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6919343B2 (en) 2002-02-08 2005-07-19 Merck & Co., Inc. N-biphenyl(substituted methyl) aminocycloalkane-carboxamide derivatives
WO2003065789A2 (en) 2002-02-08 2003-08-14 Merck & Co., Inc. N-biphenylmethyl aminocycloalkanecarboxamide derivatives
EP1545538A2 (en) * 2002-08-29 2005-06-29 Merck & Co., Inc. N-biarylmethyl aminocycloalkanecarboxamide derivatives
EP1654232A4 (en) 2003-08-07 2008-11-12 Merck & Co Inc SULPHONYL SUBSTITUTED N- (BIARYLMETHYL) AMINOCYCLOPROPANCARBOXYLIC ACID AMIDE
CN1832922A (zh) * 2003-08-07 2006-09-13 默克公司 磺酰基取代的n-(联芳基甲基)氨基环丙烷甲酰胺类
DE602005012806D1 (en) * 2004-03-02 2009-04-02 Merck & Co Inc Aminocyclopropancarbonsäureamidderivate als bradykininantagonisten
US20060173023A1 (en) 2005-02-01 2006-08-03 Wood Michael R 2-(Bicyclo)alkylamino-derivatives as mediators of chronic pain and inflammation
WO2008033564A1 (en) * 2006-09-15 2008-03-20 Hydra Biosciences Inc. Compounds for modulating trpv3 function
HUP0600809A3 (en) * 2006-10-27 2008-09-29 Richter Gedeon Nyrt New phenylsulfamoyl-benzamide derivatives as bradykinin antagonists, process and intermediates for their preparation and pharmaceutical compositions containing them
DE102007034620A1 (de) 2007-07-25 2009-01-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue B1-Antagonisten
EP2025675A1 (de) 2007-08-14 2009-02-18 Boehringer Ingelheim International GmbH Arylsulfonamide mit analgetischer Wirkung
ATE550321T1 (de) 2007-08-29 2012-04-15 Boehringer Ingelheim Int Neue bradykinin b1-antagonisten
AR068509A1 (es) * 2007-09-19 2009-11-18 Jerini Ag Antagosnistas del receptor de bradiquinina b1
WO2010057899A1 (de) 2008-11-20 2010-05-27 Boehringer Ingelheim International Gmbh Cykloalkylaminocarbonylderivate als bradykinin-b1-rezeptor antagonisten
WO2010097374A1 (de) 2009-02-26 2010-09-02 Boehringer Ingelheim International Gmbh Verbindungen als bradykinin-b1-antagonisten
WO2010097372A1 (de) 2009-02-26 2010-09-02 Boehringer Ingelheim International Gmbh Verbindungen als bradykinin-b1-antagonisten
PE20121805A1 (es) * 2010-02-23 2013-01-23 Boehringer Ingelheim Int Derivados de 6-oxo-1,6-dihidropiridazin-4-carboxamida n-sustituidas con anilino-(bencil o piridinilmetil)-carbamoilo como antagonistas del receptor de bradiquinina 1 (b1)
US8759537B2 (en) 2010-08-20 2014-06-24 Boehringer Ingelheim International Gmbh 3H-imidazo [4, 5-C] pyridine-6-carboxamides as anti-inflammatory agents
US8586604B2 (en) 2010-08-20 2013-11-19 Boehringer Ingelheim International Gmbh Inhibitors of the microsomal prostaglandin E2 synthase-1
US8937073B2 (en) 2010-08-20 2015-01-20 Boehringer Ingelheim International Gmbh Disubstituted tetrahydrofuranyl compounds and their use as B1-receptor antagonists
WO2012022794A1 (de) 2010-08-20 2012-02-23 Boehringer Ingelheim International Gmbh Pyridazinderivative als bradykinin b1 rezeptor antagonsiten
AR082492A1 (es) 2010-08-20 2012-12-12 Allergan Inc N-alquil-2-(1-(5-sustituido-2-(3-oxo-3-(trifluorometilsulfonamido)propil)bencil)pirrolidin-2-il)oxazol-4-carboxamida y su uso para preparar un medicamento util para tratar enfermedades o afecciones mediadas por receptor dp, fp, ep, ep, tp y/o ep

Also Published As

Publication number Publication date
CO6680689A2 (es) 2013-05-31
MY156233A (en) 2016-01-29
SG187835A1 (en) 2013-03-28
UY33565A (es) 2012-03-30
CL2013000310A1 (es) 2013-04-01
HK1178902A1 (en) 2013-09-19
JP2013534238A (ja) 2013-09-02
PH12013500330A1 (en) 2021-06-02
GEP20146196B (en) 2014-11-10
TW201305145A (zh) 2013-02-01
MX352548B (es) 2017-11-29
EP2606042A1 (de) 2013-06-26
CY1115933T1 (el) 2017-01-25
CN103068817B (zh) 2014-10-29
IL224039A (en) 2016-03-31
MX2013001965A (es) 2013-05-09
ES2525296T3 (es) 2014-12-19
KR20130114082A (ko) 2013-10-16
EA201201662A1 (ru) 2013-07-30
US8937073B2 (en) 2015-01-20
BR112013003752A2 (pt) 2016-05-31
TWI548632B (zh) 2016-09-11
WO2012022795A1 (de) 2012-02-23
ME01899B (me) 2014-12-20
AU2011290727B2 (en) 2015-07-16
PT2606042E (pt) 2014-10-15
JP5727011B2 (ja) 2015-06-03
KR101822371B1 (ko) 2018-01-31
AR082507A1 (es) 2012-12-12
PE20130810A1 (es) 2013-07-25
DK2606042T3 (da) 2014-12-08
CN103068817A (zh) 2013-04-24
NZ607435A (en) 2015-07-31
EP2606042B1 (de) 2014-09-03
ECSP13012495A (es) 2013-04-30
US20120208823A1 (en) 2012-08-16
HRP20141172T1 (hr) 2015-02-13
SI2606042T1 (sl) 2014-12-31
UA108765C2 (xx) 2015-06-10
AU2011290727A1 (en) 2013-03-14
PL2606042T3 (pl) 2015-03-31
EA022787B1 (ru) 2016-03-31
MA34578B1 (fr) 2013-10-02
CA2807086A1 (en) 2012-02-23
RS53622B1 (sr) 2015-04-30

Similar Documents

Publication Publication Date Title
AP3391A (en) 2-Amino-4-arylthiazole compounds as TROA1 antagonists
PL2927224T3 (pl) Antagoniści receptora
ZA201304042B (en) Spiro-oxindole mdm2 antagonists
HUE040101T2 (hu) Szubsztituált piridinon-piridinil-származékok
AP2012006641A0 (en) New compounds
ZA201207292B (en) Cgrp receptor antagonist
IL214129A0 (en) Compounds as bradykinin b1 antagonists
GB201012105D0 (en) Novel pyrimidine compounds
AP3218A (en) Compounds as bradykinin B1 antagonists
PL2294925T3 (pl) Mieszanka chipsów
PT2606042E (pt) Compostos de tetra-hidrofuranilo dissubstituídos como antagonistas do receptor b1 de bradicinina
IL223330A (en) Spirohutrocyclic Compounds as 5mglu Antagonists
PL2590966T3 (pl) Związki chinazolinowe
ZA201209495B (en) Novel methods for the preparation of p2x7r antagonists
IL223324A0 (en) Novel pharmaceutical compounds
PL391377A1 (pl) Konstrukcja mebla do leżenia
GB201002096D0 (en) Novel compounds
GB201002097D0 (en) Novel compounds
GB201002799D0 (en) Novel compounds
GB201002797D0 (en) Novel compounds
GB201002094D0 (en) Novel compounds
GB201002112D0 (en) Novel compounds
GB201000685D0 (en) Novel compounds